Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF | T.LABS.W.B

MediPharm Labs Corp, along with its subsidiaries, produces purified, pharmaceutical-like cannabis extracts and related derivative... see more


Bullboard (TSX:LABS)

View:
Post by subaru1ion Jun 03, 2023 9:28pm

LABS - Epidiolex deal IS already structured and pending

release.   Pay attention please:  CEO David Pidduck made this statement already twice or the second time might have been by the CFO...."it will change the face of the company" ...more  
Post by subaru1ion Jun 03, 2023 12:04pm

THC reduce obesity, hence increases health and reduces risk

of obesity related diseases such as diabetes, etc, etc,.  Post retirement, from 245 lbs down to 198 pounds, feeling more energetic and with no more knee joint pain.  I cannot imagine now ...more  
Comment by subaru1ion Jun 03, 2023 11:56am

RE:RE:RE:RE:"Global pharmaceutical partner" = exclusivity

You cannot replace unknown variables with hope, only the passage of time will provide solutions to the unknown variables.   For example, 2+2=?  5x6=? 10/2=?   what provides ...more  
Comment by rejajon Jun 03, 2023 10:49am

RE:RE:RE:"Global pharmaceutical partner" = exclusivity

subaru1i, there is an aspect of hope that does have some relevance in the execution of a business strategy and when investing in general.  As you note, having all the important inputs and factors ...more  
Post by subaru1ion Jun 02, 2023 6:10pm

Apotex and China?

FDA allows temporary import of unapproved Chinese cancer drug to ease U.S. shortage Qilu Pharmaceutical, which makes and markets cisplatin injections in China, received FDA permission to export the ...more  
Post by subaru1ion Jun 02, 2023 12:25pm

LABS in conjunction with McMaster University (Degroote

School of Medicine) currently have research/clinical trial within this scope.   Keep in mind, the disease is an 'autoimmune' system disease and the immune system responds to ...more  
Comment by subaru1ion Jun 01, 2023 3:38pm

RE:RE:RE:Risk/Reward analysis, fact based not emotionally driven

That is a very conservative strategy especially when applied to a young investor that has a longer lifespan and therefore is capable of assuming a little more risk in their portfolio so a good ...more  
User Avatar Image
(83)
•••
  • StarkickerX
Comment by Starkickeron Jun 01, 2023 3:32pm

RE:RE:Risk/Reward analysis, fact based not emotionally driven

If I had an MBA I would tell young imvestors to buy blue chip stocks with dividends and sit back and relax instead of screwing around with these drama-filled venture exchange head cases.
Comment by subaru1ion Jun 01, 2023 11:29am

RE:Risk/Reward analysis, fact based not emotionally driven

In summary, I really don't care what the stock price is currently doing relative to the facts because with or without a business degree or MBA, everybody should know that "money talks and ...more  
Post by subaru1ion Jun 01, 2023 11:24am

Risk/Reward analysis, fact based not emotionally driven

So a logic centric investor should be able to evaluate, retail or institutional, am I willing to buy LABS stock at the existing price and take a small risk relative to a very large reward on the ...more  
Post by subaru1ion Jun 01, 2023 10:46am

LABS future stock price with an Epidiolex exclusive using

valuation model of Pf=EPS x P/E where Pf is future stock price, EPS is earnings per share driven LABS profit margin multiplied by sales and divided by number of shares outstanding.  P/E ratio is ...more  
User Avatar Image

•••
  • Jon BrownX
Post by Jon Brownon Jun 01, 2023 9:00am

Buzz on the Bullboards: Can health care and energy stocks help “recession proof” your portfolio?

Comment by subaru1ion May 31, 2023 11:58am

RE:RE:"Global pharmaceutical partner" = exclusivity

"hope" is purely an emotional emmulation of thought with no application in the logic of conducting and executing a business strategy.   
Comment by subaru1on May 31, 2023 11:48am

RE:"Global pharmaceutical partner" = exclusivity

I hope you are right..
Post by subaru1ion May 31, 2023 11:00am

"Global pharmaceutical partner" = exclusivity

"patent THREATS" X=Epidiolex Y= business competitor(s) posing the THREAT IF X is under threat by Y THEN X is the target 'raise the bar' 'change the playing field' ' ...more  
Post by subaru1ion May 31, 2023 1:29am

LABS mentioned 'patent threats' in the more recent past and

seeing what they have done so far via the FDA, those actions could easily be applied to JAZZ Pharma obtaining an FDA approved but YET very unique CBD formulation that would be used in Epidiolex with ...more